Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells

Radiation Research

Volumn 151, Issue 3, 1999, Pages 244-256

  Kennel, S J ^a   Stabin, M ^b   Roeske, J C ^c   Foote, L J ^a   Lankford, P K ^a   Terzaghi Howe, M ^a   Patterson, H ^a   Barkenbus, J ^a   Popp, D M ^a   Boll, R ^a   Mirzadeh, S ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH 213; HERMES ANTIGEN; LEAD 209; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 13A; POLONIUM 213; RADIOISOTOPE; THALLIUM 209; UNCLASSIFIED DRUG; YTTRIUM 90;

ALPHA RADIATION; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; LUNG ADENOCARCINOMA; MICRODOSIMETRY; MONOLAYER CULTURE; MOUSE; MULTICELLULAR SPHEROID; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR CELL LINE;

ANIMALIA; MURINAE;

EID: 0032976272     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579935     Document Type: Article

References (46)

1. M. R. Raju, Y. Eisen, S. Carpenter and W. C. Inkret, Radiobiology of a particles. III. Cell inactivation by α-particle traversals of the cell nucleus. Radiat. Res. 128, 204-209 (1991).
2. 210Po alpha particles on survival and preneoplastic transformation of primary rat tracheal epithelial cells irradiated while in suspension or in the intact tissue. Radiat. Res. 136, 89-96 (1993).
3. R. H. Larsen, G. Akabani, P. Welsh and M. R. Zalutsky, The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro. Radiat. Res. 149, 155-162 (1998).
4. M. Terzaghi-Howe, J. R. Ford and J. E. Turner, Influence of cell position relative to planar alpha-particle sources on survival and preneoplastic transformation of primary rat tracheal epithelial cells. Radiat. Res. 145, 432-441 (1996).
5. T. G. Stinchcomb and J. C. Roeske, Analysis of survival of C-18 cells after irradiation in suspension with chelated and ionic bismuth-212 using microdosimetry. Radiat. Res. 140, 48-54 (1994).
6. J. L. Humm, J. C. Roeske, D. R. Fisher and G. T. Y. Chen, Microdosimetric concepts in radioimmunotherapy. Med. Phys. 20, 535-541 (1993).
7. T. G. Stinchcomb and J. C. Roeske, Survival of alpha particle irradiated cells as a function of shape and size of the sensitive volume (nucleus). Radiat. Prot. Dosim. 62, 157-164 (1995).
8. A. Deshpande, E. H. Goodwin, S. M. Bailey, B. L. Marrone and B. E. Lehnert, Alpha-particle-induced sister chromatid exchange in normal human lung fibroblasts: Evidence for an extranuclear target. Radiat. Res. 145, 260-267 (1996).
9. L. Manti, M. Jamali, K. M. Prise, B. D. Michael and K-R. Trott, Genomic instability in Chinese hamster cells after exposure to X rays or alpha particles of different mean linear energy transfer. Radiat. Res. 147, 22-28 (1997).
10. B. E. Lehnert and E. H. Goodwin, Extracellular factor(s) following exposure to a particles can cause sister chromatid exchanges in normal human cells. Cancer Res. 57, 2164-2171 (1997).
11. M. R. Zalulsky and D. D. Bigner, Radioimmunotherapy with α-particle emitting radioimmunoconjugates. Acta Oncol. 35, 373-379 (1996).
12. D. J. Buchsbaum, V. K. Langmuir and B. W. Wessels, Experimental radioimmunotherapy. Med. Phys. 20, 551-567 (1993).
13. P. L. Olive and R. E. Durand, Drug and radiation resistance in spheroids: Cell contact and kinetics. Cancer Metastasis Rev. 13, 121-138 (1994).
14. R. M. Macklis, J. Y. Lin, B. Beresford, R. W. Atcher, J. J. Hines and J. L. Humm, Cellular kinetics, dosimetry, and radiobiology of α-particle radioimmunotherapy: Induction of apoptosis. Radiat. Res. 130, 220-226 (1992).
15. J. C. Roeske and T. G. Stinchcomb, Dosimetric framework for therapeutic alpha-particle emitters. J. Nucl. Med. 38, 1923-1929 (1997).
16. R. W. Kozak, D. P. Fitzgerald, R. W. Atcher, C. K. Goldman, D. L. Nelson, O. A. Gansow, I. Pastan and T. A. Waldmann, Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-IL-2 receptor (Tac) monoclonal antibody. J. Immunol. 144, 3417-3423 (1990).
17. J. G. Jurcic, P. C. Caron, T. K. Nikula, E. B. Papadopoulos, R. D. Finn, O. A. Gansow, W. H. Miller, Jr., M. W. Geerlings, R. P. Warrell, Jr. and S. M. Larson, Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias. Cancer Res. 55, 5908s-5910s (1995).
18. C. Featherstone, Alpha-particle-emitting radioisotopes coupled to antibody for acute myeloid leukaemia treatment. Mol. Med. Today 3, 232-233 (1997). [News]
19. M. R. Zalutsky, R. E. McLendon, P. K. Garg, G. E. Archer, J. M. Schuster and D. D. Bigner, Radioimmunotherapy of neoplastic meningitis in rats using an α-particle-emitting immunoconjugate. Cancer Res. 54, 4719-4725 (1994).
20. 211At-TP-3 monoclonal antibody: Comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays. Radiat. Res. 139, 178-184 (1994).
21. 211At-labelled monoclonal antibody. Br. J. Cancer 69, 1000-1005 (1994).
22. 212Bismuth linked to an antipancreatic carcinoma antibody: Model for alpha-particle-emitter radioimmunotherapy. J. Natl. Cancer Inst. 80, 449-452 (1988).
23. 213Bi - an α-particle emitter. Nuclear Med. Biol., in press.
24. V. K. Langmuir, R. W. Atcher, J. J. Hines and M. W. Brechbiel, Iodine-125-NRLU-10 kinetic studies and bismuth-212-NRLU-10 toxicity in LS174T multicell spheroids. J. Nucl. Med. 31, 1527-1533 (1990).
25. J. L. Humm, A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy. Int. J. Radiat. Oncol. 13, 1767-1773 (1987).
26. S. C. Rockwell, R. F. Kallman and L. F. Fajardo, Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl. Cancer Inst. 49, 735-749 (1972).
27. J. M. Yuhas, R. E. Toya and E. Wagner, Specific and nonspecific stimulation of resistance to the growth and metastasis of the Line 1 lung carcinoma. Cancer Res. 35, 242-244 (1975).
28. S. J. Kennel, T. K. Lankford, L. J. Foote, S. G. Shinpock and C. Stringer, CD44 expression on murine tissues. J. Cell. Sci. 104, 373-382 (1993).
29. M. W. Brechbiel and O. A. Gansow. Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labeling of monoclonal antibodies with the bismuth-212 α-particle emitter. J. Chem. Soc. Perkin Trans. I 1, 1173-1178 (1992).
30. 213Bi. Radiochim. Acta 79, 87-92 (1997).
31. 213Bi. Radiochim. Acta 79, 145-149 (1997).
32. J. Luo and I. F. Tannock, Inhibition of the regulation of intracellular pH: Potential of 5-(N,N-hexamethylene) amiloride in tumour-selective therapy. Br. J. Cancer 70, 617-624 (1994).
33. L. G. Littlefield, L. B. Travis, A. M. Sayer, G. L. Voelz, R. H. Jensen and J. D. Boice, Jr., Cumulative genetic damage in hematopoietic stem cells in a patient with a 40-year exposure to alpha particles emitted by thorium dioxide. Radiat. Res. 148, 135-144 (1997).
34. K. Eckerman, J. Ryman, A. Taner and G. Kerr, Traversal of cells by radiation and absorbed fraction estimates for electrons and alpha particles. In Fourth International Radiopharmaceutical Dosimetry Symposium, pp. 67-81. Oak Ridge Associated Universities, Oak Ridge, TN, 1986.
35. W. Sontag, Dosimetry of α-emitting radionuclides in bone - a practical approach. Health Phys. 53, 495-501 (1987).
36. ICRU, Microdosimetry, pp. 4-6. Report 36, International Commission on Radiation Units and Measurements, Bethesda, MD, 1983.
37. J. Briesmeister, MCNP - A General Monte Carlo n-Particle Transport Code, MCNP User's Manual. Los Alamos National Laboratory, Los Alamos, NM, 1983.
38. J. L. Humm, R. M. Macklis, K. Bump, L. M. Cobb and L. M. Chin, Internal dosimetry using data derived from autoradiographs. J. Nucl. Med. 34, 1811-1817 (1993).
39. H. Sands, Experimental studies of radioimmunodetection of cancer: An overview. Cancer Res. 50, 809s-813s (1990).
40. R. B. Huneke, C. G. Pippin, R. A. Squire, M. W. Brechbiel, O. A. Gansow and M. Strand, Effective alpha-particle-mediated radioimmunotherapy of murine leukemia. Cancer Res. 52, 5818-5820 (1992).
41. 212Bi-anti-Tac. Cancer Res. 54, 4362-4370 (1994).
42. S. Mirzadeh, Generator produced alpha-emitters. Appl. Radiat. Isot., in press.
43. S. M. Goddu, D. V. Rao and R. W. Howell, Multicellular dosimetry for micrometastases: Dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. J. Nucl. Med. 35, 521-530 (1994).
44. J. L. Humm and L. M. Cobb, Nonuniformity of tumor dose in radioimmunotherapy. J. Nucl. Med. 31, 75-83 (1990).
45. V. K. Langmuir, J. K. McGann, F. Buchegger and R. M. Sutherland, The effect of antigen concentration, antibody valency and size, and tumor architecture on antibody binding in multicell spheroids. Nucl. Med. Biol. 18, 753-764 (1991).
46. P. K. Narayanan, E. H. Goodwin and B. E. Lehnert, α Particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res. 57, 3963-3971 (1997).